US Stock MarketDetailed Quotes

PBYI Puma Biotechnology

Watchlist

5.170
+0.160+3.19%

Close Apr 22 16:00 ET

249.23MMarket Cap11.49P/E (TTM)

Puma Biotechnology Stock Forum

BelleWeather

Apr 9 00:26

Small cap biopharma, undervalued

Puma biotech buys licenses for oncology treatments that have gone through testing, and brings them to market. I will hold until the ticker hits my target range (7-8 USD,) reevaluate (using FA and TA, and current market conditions to determine price channel and optimize execution,) and trade out.

Share Your Today's Profit/Loss

SlowndEasyWins

Mar 22 06:37

$Puma Biotechnology(PBYI.US)$ 🐂 like about to run 👍🏻but i am out this one frustrated me in past days

Trytosaveabit

Mar 20 22:22

News

$Puma Biotechnology(PBYI.US)$ • Puma Biotechnology (NASDAQ:PBYI) announced Wednesday that the U.S. FDA has greenlighted a Phase 2 trial to investigate its oral kinase inhibitor alisertib, in-licensed from Takeda (NYSE:TAK), in patients with breast cancer.
• The study named ALISCA-Breast1 is designed to evaluate alisertibin combination with endocrine therapy in patients with hormone receptor-positive, HER2-negative recurrent, or metastatic breast cancer who hadn’t undergone chemotherapy.
• ...

BelleWeather

Mar 9 02:11

Another inexpensive company

thats doing well while doing good.

Share Your Today's Profit/Loss

Moomoo AI

Mar 2 04:06

Puma Biotechnology's high P/E ratio is alarming due to its falling earnings. Despite investor hopes for a business turnaround, analysts remain skeptical. The high P/E and anticipated future earnings drop make current prices seem unjustifiable unless conditions drastically improve.

Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 31% Price Boost Is Out Of Tune With Earnings

BelleWeather

Mar 1 10:37

A risky small gamble.

biotech with promising pipeline. management are true believers.

Share Your Today's Profit/Loss

Trytosaveabit

Feb 13 21:37

Update

$Puma Biotechnology(PBYI.US)$ Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
7 MINUTES AGO, 8:30 AM EST
VIA BUSINESSWIRE

SlowndEasyWins

Jan 10 06:45

$Puma Biotechnology(PBYI.US)$ pt 7.8 lets go !!!

Trytosaveabit

Nov 10, 2023 04:48

Nice!

$Puma Biotechnology(PBYI.US)$ Still not huge! But day 11 of going up up up! hehehe

Moomoo AI

Nov 9, 2023 19:01

Puma Biotechnology's EPS declined last year due to unusual items, which potentially distort earnings depiction. Additionally, margins, forecast growth, and ROI need consideration. Also, note four warning signs for the company.

Investors Can Find Comfort In Puma Biotechnology's (NASDAQ:PBYI) Earnings Quality

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall